Assessment of hepatic steatosis algorithms in non-alcoholic fatty liver disease

被引:0
|
作者
Eremic-Kojic, N. [1 ,5 ]
Deric, M. [1 ,5 ]
Govorcin, M. L. [2 ,5 ]
Balac, D. [3 ,5 ]
Kresoja, M. [4 ]
Kojic-Damjanov, S. [1 ,5 ]
机构
[1] Clin Ctr Vojvodina, Ctr Lab Med, Novi Sad, Serbia
[2] Clin Ctr Vojvodina, Ctr Radiol, Novi Sad, Serbia
[3] Inst Publ Hlth Vojvodina, Ctr Hyg & Human Ecol, Novi Sad, Serbia
[4] Univ Novi Sad, Fac Sci, Dept Math & Informat, Novi Sad, Serbia
[5] Univ Novi Sad, Fac Med, Novi Sad, Serbia
关键词
Non-alcoholic fatty liver disease; NAFLD; algorithms; body mass index; abdominal obesity; GLUCOSE; TRIGLYCERIDES; PREVALENCE; PRODUCT; RISK;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In order to optimize the identification of persons with non-alcoholic fatty liver disease (NAFLD), several algorithms for hepatic steatosis were developed. These available algorithms, as well as an algorithm, derived using biochemical and anthropometric data of our participants, are compared in a cross-sectional pilot study. Material and methods: We included 77 participants with abdominal obesity: 43 with NAFLD and 33 without NAFLD. Body mass index (BMI), waist circumference (WC) and hip circumference (HC), systolic and diastolic blood pressure were assessed. Fibrinogen, high sensitive C-reactive protein (hsCRP), aspartate aminotransferase (AST), alanine transaminase (ALT), gamma-glutamyl transferase (GGT), uric acid, ferritin, glucose, insulin, homocysteine, lipid status parameters, apolipoprotein A-I, apolipoprotein B and Lp(a)-lipoprotein were measured. Fatty liver was assessed by ultrasound with the presence or absence of hepatic steatosis. Discovering the most significant factor in the presence of NAFLD is assessed through logistic regression modeling. The predictor variables were chosen according to an algorithm derived from conducted factor analysis and other available algorithms for hepatic steatosis. Results: Participants with NAFLD had significantly higher BMI (34.38 +/- 9.73 vs 28.05 +/- 4.79 kg/m(2), p = 0.001), WC (108.05 +/- 11.47 vs 96.15 +/- 14.27 cm, p = 0.001), HC (114.93 +/- 11.01 vs 108.21 +/- 9.82 cm, p = 0.050), systolic (128.98 +/- 8.67 vs 122.42 +/- 10.62 mmHg, p = 0.010) and diastolic blood pressure (83.64 +/- 5.94 vs 78.33 +/- 7.57 mmHg, p = 0.001), AST (23.93 +/- 6.91 vs 21.70 +/- 5.21 U/L, p = 0.014), ALT (30.50 +/- 13.70 vs 23.00 +/- 11.75 U/L, p = 0.007), hsCRP (4.34 +/- 5.56 vs 2.98 +/- 2.34mg/l, p = 0.004) and uric acid (358.02 +/- 83.29 vs 296.78 +/- 84.54 mu mol/l, p = 0.001), in comparison non NAFLD. Logistic regression model with algorithm derived from factor analysis showed the best performance. From other available algorithms, only fatty liver index (FLI) and hepatic steatosis index (HSI) had statistically significant discriminatory power. Conclusions: Elevation of WC, HC, BMI, DBP, SBP, Fbg, hsCRP, glucose, and uric acid, incorporated in our hepatic steatosis prediction model, had the best predictive power among all assessed algorithms.
引用
收藏
页码:10 / 16
页数:7
相关论文
共 50 条
  • [1] Assessment of hepatic steatosis algorithms in non-alcoholic fatty liver disease
    Kojic, N. Eremic
    [J]. CLINICA CHIMICA ACTA, 2019, 493 : S362 - S362
  • [2] STEATOSIS ASSESSMENT BY CAP™ IN PATIENTS WITH ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER DISEASE
    Beaugrand, Michel
    Carmona, Damien
    Ziol, Marianne
    Perlemuter, Gabriel
    Naveau, Sylvie
    Prevot, Sophie
    Fournier, Celine
    Sandrin, Laurent
    Miette, Veronique
    Sasso, Magali
    [J]. HEPATOLOGY, 2011, 54 : 1147A - 1147A
  • [3] Non-invasive assessment of liver steatosis in non-alcoholic fatty liver disease
    Kan, Hiromi
    Kimura, Yuki
    Hyogo, Hideyuki
    Fukuhara, Takayuki
    Fujino, Hatsue
    Naeshiro, Noriaki
    Honda, Yohji
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Hiramatsu, Akira
    Imamura, Michio
    Kawakami, Yoshiiku
    Aikata, Hiroshi
    Ochi, Hidenori
    Arihiro, Koji
    Chayama, Kazuaki
    [J]. HEPATOLOGY RESEARCH, 2014, 44 (14) : E420 - E427
  • [4] Pathogenesis of hepatic steatosis:The link between hypercortisolism and non-alcoholic fatty liver disease
    Giovanni Tarantino
    Carmine Finelli
    [J]. World Journal of Gastroenterology, 2013, (40) : 6735 - 6743
  • [5] Role of exercise in the mechanisms ameliorating hepatic steatosis in non-alcoholic fatty liver disease
    Russell-Guzmán J.A.
    Karachon L.
    Gacitúa T.A.
    Freundlich A.
    Poblete-Aro C.E.
    Rodrigo R.
    [J]. Sport Sciences for Health, 2018, 14 (3) : 463 - 473
  • [6] Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk
    Drapkina, O. M.
    Korneeva, O. N.
    [J]. RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2016, 12 (04) : 424 - 429
  • [7] Ticagrelor, but not clopidogrel, attenuated hepatic steatosis in a model of non-alcoholic fatty liver disease
    Oh, Hyunwoo
    Lee, Hyo Young
    Park, Huiyul
    Jun, Dae Won
    Yoon, Eileen
    Ahn, Sang Bong
    Lee, Chul-min
    Kim, Mi Mi
    Kang, Bo-Kyeong
    Sohn, Joo Hyun
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 : S728 - S729
  • [8] Pathogenesis of hepatic steatosis: The link between hypercortisolism and non-alcoholic fatty liver disease
    Tarantino, Giovanni
    Finelli, Carmine
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (40) : 6735 - 6743
  • [9] Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
    Nier, Anika
    Huber, Yvonne
    Labenz, Christian
    Michel, Maurice
    Bergheim, Ina
    Schattenberg, Joern M.
    [J]. NUTRIENTS, 2020, 12 (03)
  • [10] Non-alcoholic fatty liver disease: from steatosis to cirrhosis
    Leclercq, Isabelle
    Sempoux, Christine
    [J]. ACTA ENDOSCOPICA, 2006, 36 (03) : 299 - 314